ࡱ>  ;bjbjVV 7j<<y3vv8-<00)))///////24/)!%))/4/ )L/)/+|T=-ः#uA,//<00S,T5$T5$=-=-0T5m-<)))))))//!)))00))))T5)))))))))v :  THE ORGAN PROCUREMENT AND TRANSPLANTATION NETWORK (OPTN) KIDNEY PAIRED DONATION (KPD) PILOT PROGRAM AGREEMENT TO PARTICIPATE What is Kidney Paired Donation (KPD)? KPD is a transplant option for those waiting for a kidney transplant. It is for patients who have a willing living donor who is incompatible (a poor match). Reasons for incompatibility could be an incompatible blood type or incompatible tissue type as identified by a positive crossmatch. KPD results when one donor (Donor #1) is willing to donate to a spouse, friend or relative (Recipient #1), but cannot. The Organ Procurement and Transplantation Network (OPTN) KPD Pilot Program (discussed below) helps find another incompatible pair (Donor #2 and Recipient #2) who might wish to exchange donors. If Donor #1 is compatible with Recipient #2, and Donor #2 is compatible with Recipient #1, two transplants can be pursued. Sometimes, more than two compatible pairs can be matched to each other. This results in more than two life-saving transplants.  KPD programs may also include individuals who wish to donate to any individual who is currently waiting for a kidney transplant. These individuals are called non-directed donors and are not linked to a specific potential recipient. An exchange started by a non-directed donor is called a donor chain (see diagram 2). In a donor chain, the non-directed donor donates to a recipient whose intended donor would then donate to another recipient. The donor at the end of the chain will donate to a candidate on the deceased donor waiting list.  What is the OPTN KPD Pilot Program? The KPD Pilot Program is part of the Organ Procurement and Transplantation Network (OPTN). The OPTN is managed by the United Network for Organ Sharing (UNOS) through a contract with the Health Resources and Services Administration (HRSA). The OPTN registers and tracks everyone who registers in the Pilot Program and works with transplant centers and organ recovery agencies throughout the United States to search for cases where the donor in each pair is compatible with the recipient in another pair (or multiple pairs). The goal of the OPTN KPD Pilot Program is to identify as many compatible pairs as possible and to consider needs of special populations, such as children and highly sensitized recipients. What will happen if a recipient/donor pair agrees to join the OPTN KPD Pilot Program? Once a potential living donor and a recipient are found to be blood type or tissue type incompatible, their medical data is entered into the OPTN KPD database, which is used to track everyone who is registered in the Pilot Program. This database allows a computerized matching program to run and identify compatible recipient/donor pairs. This exchange match program is routinely run about every 4 weeks. If a potential exchange pair is identified, the match will be reviewed by the transplant surgeon, physicians, and transplant center program staff. If the match is favorable, the potential living donor and the recipient may be asked to provide a blood sample for crossmatching (mixing of blood between recipient and donor to establish compatibility). The recipient/donor pair will be notified about whether the crossmatch results indicate that the exchange offers a favorable arrangement for all participants and whether the paired exchange will move forward. Once all participants agree to go forward with the exchange, the medical information of both the potential living donor and recipient (as applicable) will be shared with the participating transplant center. Any further evaluation requested by the surgeon or physician to determine the potential living donors or recipients eligibility will be completed. After the physicians and surgeons accept the medical eligibility of all the participants, the transplants can be scheduled. In two-way and three-way exchanges, the donation surgeries are scheduled to begin at the same time. Recipient surgeries begin after donor surgeries. In donor chains, surgeries may or may not occur on the same day. The recipient/donor pair will remain in the OPTN KPD database as long as they are medically acceptable and are willing to participate. Recipient/donor pairs should discuss when they will be contacted about potential matches and other information with the transplant center. What personal information is needed in order to run the match program? The OPTN KPD database requires the recipients and potential living donors name, date of birth, blood type, prior living donor status, genetic tissue type, and any tissue markers (antigens) that need to be avoided in the donor in order for a compatible match to be made. The database allows for potential recipients and donors to indicate where a potential donor is willing to travel to donate. How will personal information be used? The personal information entered into the database will be used to identify other potential recipient/donor pairs. Potential living donor data will be shared with the surgeons, physicians, and transplant team at the potential recipients transplant center. Data will be stored indefinitely in a password protected system. Only designated staff at your transplant center and UNOS staff have the ability to access the data in the system. The data may be released in aggregate for reporting purposes according to the current OPTN data release policy. Patient-level, de-identified data may be released after a standard Data User Agreement is signed. The data may be used only for the purpose specified in the initial data request. Center-identified data may be released to bona fide researchers after a concept paper is approved by the UNOS Research Department and an agreement about using center-identified data is signed by the researchers. Requests for patient-identified data from bona fide researchers require the submission of a concept paper (including security plan for the data) for review. A Data Release Agreement must be signed by the researchers, documentation of IRB approval must be submitted, and the request must be approved by theOPTN Policy Oversight Committee and HRSA. How will medical information be kept confidential? Prior to locating a possible match, a potential living donors or recipients information will not be shared with anyone outside of the OPTN KPD Pilot Program or the participating transplant centers without the participants clear permission. Access to the database will be through a secure, password protected system. After a potential match is identified, the matched recipients health insurance may provide the matched recipient with the name of the actual matched donor on an Estimate of Benefits form that is sent to the recipient before surgery. This means that recipients may learn of their actual matched donors identity. Otherwise, the participants medical information will remain confidential to the extent required by law. Potential living donors and recipients should discuss the confidentiality rules at the hospital with transplant center staff. What are the risks of participating in the OPTN KPD Pilot Program? There is a risk of the loss of confidentiality of medical information if the steps outlined above are not followed. If an exchange pair is identified and the recipient/donor pairs agree to proceed with the surgery, they should understand that, as with any transplant and donor surgery, there are unexpected events that may occur with a paired donation transplant. An event may occur in the operating room that makes it necessary to stop a donor procedure. In this case, one recipient would not receive a kidney. If a donor or recipient surgery has begun, this surgery will continue even if another surgery in the match must stop. If it is necessary to stop a recipient surgery, a kidney would be available. This kidney would be given to a recipient on the deceased donor waiting list according to OPTN policies. Possible risks for recipients and donors include (not limited to): Surgery is major and requires anesthesia; thus, there are possible medical complications including injury and death. The organ may not function after being transplanted into or may be rejected by recipient. Scars, pain, fatigue Negative psychological symptoms (such as anxiety, depression, etc.) are possible after donation. Possible impact on lifestyle Potential financial effects Potential living donors and recipients may decide to withdraw from participating in the OPTN KPD Pilot Program at any point without penalty. What are the risks of participating in a kidney paired donation when the kidney is shipped to the recipient transplant center? The living donor kidney will be shipped via ground and/or air transportation to the recipient transplant center. This form of transportation has the risk of courier delay, flight cancellation, or flight delay which would extend the cold ischemic time of the kidney. Cold ischemic time is the amount of time an organ spends being preserved after recovery from the donor. Too much cold ischemic time can affect the quality of the organ for transplant. With clear-cut, organized plans, this risk is decreased. There is the risk of problems outside of the transplant centers control such as a plane crash, terrorist activity, and natural disaster. There is risk of damage to the kidney during transport which would be discovered at the time of inspection of the kidney at the recipients transplant center. What are the benefits of participating in the OPTN KPD Pilot Program? There is no guarantee that a potential living donor or recipient will receive any benefit from participating in the OPTN KPD Pilot Program. Recipients may receive the benefit of a compatible living donor kidney transplant by participating in the program. The risks and benefits of the donation surgery and the transplant surgery will be discussed with the potential living donor and recipient in detail by the appropriate transplant center if and when they consent to move forward with a kidney paired donation. What are the chances a match will be identified through the OPTN KPD Pilot Program? It is not known if or when any given recipient/donor pair might be identified as part of a possible matched pair. The more participants in the program, the more likely it is that any given recipient/donor will be part of a pair identified for a possible donor-recipient exchange. What are the alternatives if a recipient or a potential living donor decide not to participate in the OPTN KPD Pilot Program? Potential living donors and recipients have the right to change their minds and end the process at any time. There is no penalty for doing so and the decision remains confidential; an explanation of the donors decision not to continue with the donation is only disclosed if the donor agrees. Potential living donors and recipients may participate in other paired exchange programs regardless of whether they participate in the KPD Pilot Program. Potential recipients should discuss the alternatives with their transplant center staff (such as receiving a deceased donor kidney through the national waiting list maintained by the OPTN). One option for potential living donors who decide not to participate in the KPD Pilot Program would be to donate a kidney to someone else waiting for a kidney transplant. What costs or payments are involved? There is no cost for registering and there will be no payments or compensation of any kind for participating. Potential donors need to discuss the financial risks of participating in the OPTN KPD Pilot Program and the resources that may be available with the transplant center. There are national and local resources available, such as the National Living Donor Assistance Center, that may be able to assist those who qualify. All local resources are not the same, depending on the area. In certain cases, for example, qualifying donors may be reimbursed for limited travel and subsistence expenses. Ask your transplant center about the resources in your area and nationally that may be able to assist living donors. Whom should recipients and potential living donors contact if they have questions? If you have questions, please call Please note that this document is only a consent to participate in the OPTN KPD Pilot Program to find potential matches. It is not a consent to be a KPD donor or recipient, and it is not a surgical consent. I have read the above document, understand that this document is only a consent to participate in the OPTN KPD Pilot Program allowing my personal information to be entered in the KPD database, that it is not a consent to be a KPD donor or recipient, and is not a surgical consent. My questions have been answered, and I agree to participate in the KPD Pilot Program. ___________________________________________ _____________ Printed Name Date _____________________________________________ Signature _____________________________________________ Printed Name of Witness ______________________________________________ Signature of Witness     <RXY_g4 C ɻzcLc5c-hoRhlDB*CJOJQJaJmH phsH -hoRhn B*CJOJQJaJmH phsH -hoRhVB*CJOJQJaJmH phsH -hoRh |B*CJOJQJaJmH phsH hoRhz56CJaJhoRhM%d56CJaJhoRhiB56CJaJh/LhiB5>*CJaJhM%dhiB5CJaJh |5CJaJhM%d5CJaJhM%dhM%d5CJaJhM%dhv5CJaJ<gh !~s $dha$gdJdhgdlDdhgdQM $dhxa$gdB`M$dhC$Eƀ[a$gdM%d $dha$gdM%d $dha$gdiB 2 3 C D E t w x y | ѽѦxяaJ?hQMhQMCJaJ-hQMhQMB*CJOJQJaJmH phsH -hQMhVB*CJOJQJaJmH phsH -hoRhUTB*CJOJQJaJmH phsH -hoRhzB*CJOJQJaJmH phsH -hoRhB*CJOJQJaJmH phsH 'h2gB*CJOJQJaJmH phsH -hoRhVB*CJOJQJaJmH phsH -hoRh |B*CJOJQJaJmH phsH  = ? !"#G6akPQRŵŵŵŵŵŵŵwh\hPh\whECJaJmH sH h'73CJaJmH sH hHhECJaJmH sH hoRhzCJaJmH sH "hoRhz56CJOJQJaJ *hGhImCJ]aJj *hImCJU]aJhImhQMCJOJQJ]aJhImh>(CJOJQJ]aJ%jhoRhzCJOJQJUaJ-hoRhlDB*CJOJQJaJmH phsH !#GRSg,m$ & Fdhxa$gdM$ & Fdhxa$gdB` $dhxa$gdB` $dhxa$gd+t $dha$gdoRdhgdz $dha$gdIm RSch %<ABFKOT]gn梗{{pbTI>hoRh|CJaJhoRhiBCJaJhoRhUT56CJaJhoRh |56CJaJhE56CJaJhoRh)\56CJaJhoRhiB56CJaJhoRh&CJaJ-hoRhlDB*CJOJQJaJmH phsH hoRh@IZCJOJQJaJhoRhn CJOJQJaJhoRh |CJOJQJaJhoRhlDCJOJQJaJhoRhoRCJaJ+9OT\]nrhinĵ{sh`hhUhMhhlDCJaJhlDh|CJaJhKCJaJhlDhiBCJaJh@IZCJaJh'73CJaJh/LhiBCJaJh/Lh |CJaJh |CJaJh|CJaJhoRCJaJmH sH hHhoRCJaJmH sH hoRCJaJh5CJaJhoRh |CJaJhoRh|CJaJhoRhiBCJaJhoRh@IZCJaJZrs)i#Eq1X^noĹwld\h5CJaJh;CJaJh/LhiBCJaJh/Lh)\CJaJhImhMCJaJhImhGCJaJhImh)\CJaJhImhoRCJaJhImhn CJaJhImhiBCJaJhImhlDCJaJhlDhiBCJaJhlDhlDCJaJhlDCJaJhlDh)\CJaJh)\CJaJ$/34lm@DIMV_Q õvn`U`MhoRCJaJh56CJaJh/LhiB56CJaJh1@CJaJhEhlDCJaJhEh|CJaJhEh)\CJaJh5CJaJhEhoRCJaJhEhiBCJaJhEhiB56CJaJhiBh/LhMCJaJhMCJaJhiBCJaJh/Lh)\CJaJh)\CJaJh/LhiBCJaJm@   7 ### $dha$gdoR $dhxa$gdoR $dhxa$gdB`Q$ & FdhxEƀ)oa$gdB` AGQZ[h~K+8|9=QW  ꬡ~shhSWhlCJaJhj:^hjCJaJh@CJaJhjhjCJaJhSWCJaJhjCJaJhSWhjCJaJhjhjB*ph64h|CJaJh+tCJaJh/Lh)\CJaJhB`CJaJh@IZCJaJh)\CJaJh/LhiBCJaJh/LhoRCJaJ%   7 ##########H%I%%S&T&U& 'M'νߡ߅zogo\Qgo@ hZhZ5B*CJaJphhSWhSWCJaJhSWhZCJaJhSWCJaJhoRhZCJaJh/LhZCJaJhoRh|56CJaJhoRhUT56CJaJhoRh;56CJaJhMB*CJ\aJph hoRh;B*CJ\aJph hoRh2gB*CJ\aJphhoRhiB56CJaJhoRhImCJaJhiBCJaJ#I%T& 'M''(1((((Y)Z)),,D-D.G/H// $dhxa$gdB` $dhxa$gdoR & FdhgdZ hdh`hgdZ$ & Fdhxa$gdSW $dhxa$gdZM'''((#)(),)2)F)G)V)X)Y)Z)))))))) **H*N*øΜ΅seWeWeέLAhoRhIhECJaJhoRhX3CJaJhoRh|56CJaJhoRhiB56CJaJ#hoRhSW56B*CJaJphhiBCJaJhoRhzB*CJaJph hoRhz5B*CJaJphhoRhB`CJaJhoRh|CJaJhoRh;CJaJhoRhiBCJaJhoRh@IZCJaJhZB*CJaJphhZhZB*CJaJphN*f*i**+++++++++ ,,,%,',,,,,, -+-,-1-4-:-D-_----|qi^qh/Lh@IZCJaJh@IZCJaJh/LhiBCJaJhUT56CJaJhz56CJaJhB`56CJaJh/LhiB56CJaJh|56CJaJh=56CJaJhoRh&CJaJhoRh+tCJaJh0A{CJaJhoRhX3CJaJhoRhIhECJaJhoRhiBCJaJ!----------. .:.;.C.D.... / //F/G/H///00000ݽݲէէݟ~seZh&56CJaJh/LhiB56CJaJhJhSWCJaJhSWhSW56CJaJhJ56CJaJhSWCJaJh\CJaJh/Lh@IZCJaJhB`hB`CJaJh];CJaJhB`CJaJhiBCJaJh@IZCJaJh/LhiBCJaJh|CJaJhX3CJaJhzCJaJ/006171]223`4a44X7Y77777889 $dhxa$gdJ $dhxa$gdSW$dhx[$\$a$gdyB $dhxa$gdSs $dhxa$gdrrgdv) $dhxa$gdB`00001#1&1'1-1617181\2]2^222 3 3136373A3N333333øέΥzozozgo_ooWLhJh@IZCJaJhB`CJaJhSWCJaJh1VCJaJh/LhiBCJaJh@IZCJaJh&CJaJhrrCJaJhv)hv)CJaJh1@CJaJhv)CJaJhB`56CJaJhUT56CJaJhrr56CJaJh/LhiB56CJaJh/Lh@IZ56CJaJh@IZ56CJaJh\56CJaJ333333333334%4_4`4a444 5555666/60616q66V7W7ļԴ}yooeWh ";h ";5\mH sH h ";B*\phhJB*\phh _hJhv)B*\ph hv)hv)hv)hv)B*\phh/LhiB56CJaJhiBCJaJh|CJaJhJCJaJh0A{CJaJh@IZCJaJh/LhiBCJaJhJhiBCJaJhJh@IZCJaJhJhJCJaJW7X7Y7\7]7^77777777777T8n888888E99999:";ٽٽٲ眔~s~k`UJJUhJhJCJaJhv)h!]CJaJhv)h@IZCJaJhSWCJaJhImhGCJaJhImhSWCJaJh _hSWCJaJhJCJaJh@IZCJaJhv)h\56CJaJhv)h\CJaJhv)h@IZ56CJaJhv)hx56CJaJhv)hiB56CJaJhv)hiBCJaJhQMhQM5\mH sH 99:::;:::::::::;2;3;4;c;x;y;{;|;~;;;;;gdM%dgdiB O gdiB $dhxa$gdSs";#;y;z;|;};;;;;;;;;;;;h8xh>(h>(B*mHnHphuhjhUhv)hiBCJaJhv)h9CJaJ;;;;;;;;;;;;;;gdiB 5 01h:pM%d/ =!"#$% Ddk j  FA?Picture 1b lӠCQNsDn lӠCQNsPNG  IHDR뷵sRGBKIDATx^-EKFhiQ6haH&MDmڠIԦMFmش]:1873;8wvkgg۷@h6!M" jji@@z rF!@a@" jji@@z rF!@a@" jji@@=;Q\4*'IZsQś8&B2*Qj-jqfZ&`ND:Qq@Z@DW!`ND:Qq@Z@DW!w I5{4KT<Ŗ?rl_0Զ~lHd,sG{@6.A\J7V%!YLNxn6Fu,@Y4K%Y!g{HgxffnGq.ϼ[֤rQst_K3yi`ksfkkx.y3leO=C|= $)|{sH]\˪T\EFvWAǐܛi}` 64Vh8"rzofHl)Tm`M;e NdJX~ҐWʇO <q}+q2ӌh kW>;)B9JX9hV>[Ox34N'O4N/o%<@z35| ?gz@V;_[~׃ Ж@N?A7Y7`gO_G}Qݻw/ʘOtJ{}_e~}IffNK}Lߗ ¼l~y&*ϖ?FU-E;M/) twVGn>r'xX2J͟к}.ﱘRS%3 iQL|׮]mqT|Kf\f:~\3EG_ԏ,ϟ?8ܼy ɟ֒ٞs$IW_ʞ\H5B8N+ u|37`++%@8 X_\` !':F= 3i䣥wR]q$Ќ~'bڜN^9Z}dϋ/ Q } +W!5~과9宾{JFẃO^\By"5#dƦrO^P^}ԦǏW\78MID+՗0TOMjt¥>CR;f7i%Y'jqFƴh zʏxtx4BjKg`Cv`c^mEMB;[v.s%h@@ByyM%H5?ᡜ-Y|v >ZC<ʾ¼YtW+YmCQǘvEwԧN[mP9.m]9Z>Ѣn}c9-ltx6ĎN @-Gmwk]γ;+G`6GJ֩[~jN&5a)i'|Ts?c& tc^5h18Ǒ9若CI-'&jSke:s|O~Ǽ鮧;>&z@N] vǼuSBv,C"6;[Ft=1Nw)KtͣKcQʜˀ3+Iww̳}P t(SFӝzoܸatߵ<x81ov߽{vd#@' nwz}\s;vǼ5TK%'$0{]64wmAes9Zפ'ՏAwhѣG9H{wcp;vbч%r15\">crO7chjּlU_gk FʟiOBz1ak8/t1p- u@dҠ˗{~ ܨř9}q;њoi(4xHewg1JF"lhB|R/9\$ܨřPZ]R-oA1-輱\;ݵK?PIלݬ`6HdB$޹ݨJeO ={O֛Ź!yA%u|75˿zj c>Q4="ؐ2 xy5FY n6nf@lx{xZqE¼(L ְ~_ 0oUkgb`]i[k1VHYt{?&!d2`{8'k{h3ܫwdZ]5lw1I%J};M%i0́i2}3=ó'{!ئ6\qK$Tb%=4VAS{<ly) lDպcblNn$lF쌽<Ih]JGܿ?SVWYT261rxf۬@v_s}:kfQ]cv6Ew,{mC;mm{Z Iq͞x=˳W땯dG[ Cf;{l;=lnVX]֢N\&c>W!nNHPHVƨ}r*aN\1ML.pc[`tjD!M.N:׊ut Єntt޶pl!jK-e>'4!BӞ4f˄䒵Эa6m7^\*yg}^.0NwF'Q>~_#UIj8 DN\c>).{uD<^ƍc>ʯ(bi9*]47 MhN\DBvG˰S3C%Yt/zO ;X9P9-ٳiYiG:K[ DZvgwgxy-]Qw֭[ZyԪ_KjqoY\PS#dUvtPסEwmz6he}"nSjTLK˳̢N;s9lwfh0檜z%5liʕ+o D"RIݝ닔(@K7vA?|PcMZHSXUA#@ҌNiI{5k vZ4pf^]v O'K∫4`C^BQ͑kFBh^xܽL#ML~qkIv<>yDJ3j݈u46Z鞋Ə9s#7aX:1rK=83KyL @:)y,bѽYs@ӀКNcli ĶLh,26e}@[="uם"+՜ڵk;d.KQWK8 44;Ou[dU=LVLs뜍"4dɶJ <0֯uilgOWuǴ߯X΁,_fl}?K}Ӵ̆jBjZt5ӵ$RV V:c I#7!re:,Ld2s7Y Wo(Xnhw\%3f 73'K[4i]'Q/xUl  C Ab9(kxg8 o9ng9(kxg8 PNG  IHDR󺂁sRGB pHYsod8IDATx^=lJ" 5J*.R9eC5.nD e .]::pDEŝٗ{y/w"9wgg>ۙ=V:8@@{{ ! b@@kCs@68dʘ  Ls@)c2eH@s@P7 1@@uC@s@`@9 }}}} Vz&@y@@q4\YQ,IRX [JuCKA@4T @,%hh6bB -uPLP1P  4 gCzM㙰$^jb\~8P4;9^udXHV$jWH*B@!] DIMt::Mi!KhX@p$h,4/SXb;04k46ap}4W Ez"75Y|sZ^|f_yq 9ց\' Qsd:-[YFL{;2^Qw$s&9*jԝB2beE\\;<-6  .s@XL/ei1  U.1I$/WzdvM"sf9 ȥei;Q40@kC~ D0ސbzY]۠WMYOmjxwh? Nvh3<ݞyUnqrVœnXX$Mc%Asp@kѐX ΫܥS+*y7)q8v:[:+t:(WR3,, A9-F"W ;ggDr0, \츬SJ A24 oA%\ zX)ǝĞ_Up=ޙ9e*gc~1:QHvfZR@J5Ɵ@% go|0z"1ZiŮ [z%&?fdUBHfRXX,dˠUfǰYf綇^Dc13ܵЉj AT5~6ف-aBgDNP;b  `DC+%A@4ԎXA 7AI # Vp/uX1a$8Khȿ7jڗ%mt\ɦx ܋f Ck 6AW-@^DCq7_gl_Q}pt8l{ߦNT^$+dLJ; T$B5` 9ܻɶy/_v/| '1D@$/I  %K4L_ E5ʓ3CBJE%("[4RUʔuC1 ~4 pJh8Ғe8ϸǧ$RVbrg*wqW6ATi*<[Ãx`4eoduyZ}1ԦGdI< R#/09gu¼Nd(n -pwby8ywpsU_Y;zovyy dbFC&NgFiU'̜A&|xv[p$gRcJg)X~Xҩ $2+o'3X~I,j3]ȍiq-LYH4D^ Ӌ] ᦣGڝL1rUN<::2b pm 7ᕶ`Kĵ z7[rdTzZ{ͦkϒ ֍5MwיlP.ϯ3eQ LP@43+P;K&Zvs Sfr},%$eY[4unRnVzC{TOG%H^"R!m-dXRo6>MFK"ʵgYj'kC& HjFi2>J1Aq)pI=\/nߡ XPd`%)xnw$L~z 2K7u8b"m(T@@9|OYg6tzXLKy[Q@Qkup&`mh׼D/lX #"C6l8+Aд6 k#mP@Ԇ3`mia:M+am'ݵDw}keXhIDL`md Q u X&f@ ?8ֆκ=P@tϧFYQ2K)ֆBz( g kCzx&{M@dثh'n;KTp6yM=Ѱ | u Vфd'nX6cmSk[S bu8kC&& D}r 5@\>$ vՒu8kCIֆH#G]W7RD ::p6>$Pp}s fb`.O."mR, KAU%')):G<::#!bI{}@hD@dc4&9{}j^'yGDO2eySӔʺ`8HpBr'˳x2MIfI3'0`ýސ"N*ȳsgWTXXxHɔRM#ʓX?*uSDmbO<۱/Mmͥ]v]6|{80 xK5E1LEmW-d#j+?Ǽ>W9GkAy:,,nSpLb˻=GH,ب]v^=vzabab'1&4 q3$KkÉe@Ja.9۷?#/ h1{^nq♄7+ESNCgLr/롈:f)\&m𣭎oH|~~N?uC Z0o ZX”Uf'zQ7} pOq?PH9]q2zhw ~> QlW [wE 39[gyx)4:B~~ʅBA  h@*&:6T" ^cN fEg켁F֤'bmY  `DCuA4@4bA,#hhà.&B,e -sDPXe  j @4aP@@DCM`!@29 h"h ,ĂXF2A]M,023&tRU4HZLL@㦻.1VH X ߈=b4V$L|lͳof Fa'15 hD~ÝXj=(>ewpuh.Qc7W7&gzY`u4\yf4us=ݖwK$s-T,: W 2Ϗ)S*_llyW,Sqڻa_Y팆Hk֒ ȼ.ܘt{a'є/蝏Uʐ&4$椿 Xnliut矋4CaW7Ley8 _̪x(+dnR<`k@cbH F~ӛ6tJB+9(tMՈǏ/..4Ӟh4]Gsn2>΢ 3=1Ae;.9I3{&J7V?hbr YϬ*4v6SoNsm(oǽ+Beu9ӆ)3fW6:7iVtK͛7/XqNɠ@xA^i ֻJY!gqu^V/=cXVfӵg u&&';찋vf96h(2foUSoDFaKUqæZpRStqD;-Mo <7m-dۭ(3g6>]7vAtbU~S~ÞܭG%[Ms=<4$,(u~A ')xزXm, ꜥYIJ(%j˕\e놱"ak+h'ʌ䣎}䫦jpCEU?.ݔiFH{)TFXBMROoP5DND4TQzohHRt!`VQa2/kguР ߉jZrn6~6g@ݪ( _4sxP3RVDUuoU)9 d:ަnhX\-q$_3_?3\+NTthGT-ω社h嘥VO(ÉȔ 'aZ"hx;ENAB)U9DIW3cu8kC?Ņ_fZ# `mh[Q_~!_: &!fFo^s˪`x `m /x5}U P*KkC}o( ?Og5 ƹ?6ZE/ }vhkCku( 3W4Ob x>;6gk.6@zgckkP;VaDS(zj,-<mc*^xqT3ChND r)KIJо& ktn5L X zNS\x\߸ֆ.zM:u4R^@4:pÉXz;1Dk\eXZ@ TSm@k'bmDd gCm-Br29JNRͦq~"yY28x2݋7''7K ^$7n2)-~Bf_JoZd 8McoV ZiON7sd 3;ѱY\k> ֻ<^eX_ ۵Fg}͛_V{;Ft; s+n9G6])a%jV\Ƣ\-PxC`4S6X\&VVt4G.Dt hn81Ǭ_an@1kD 5‹rz烁) |3rLfIMp ȶ"s" ^皘Z';4ߺy0?g:JneJPgBaߢ,ܕ[XVIwo7pVdܣvt4 XY@\}Q'gQ⎞}$+z5=n+oDZ'6斏AYv xK¬n Sr9"/}b4mb&<_SW}4gjyxPo3 LS Ĺx(ý3Ƨ,-ȋYb)ɳؑ)yǩ_}ÕKљZ6b߈{T 699焊;/V'ꫯv20=VDnqb.=ߒ]=>t,NL sX=KZ>lY!H5ʬ!6R'z)M(D5CjX&j<w]TJʕ!P u'_'bmhӡ^9}}hֆZ*Z]IK $LcD u7HĊS`n0yFÉXb( Pz#W{fo P3b.a+1hmzTc ; nhtj"S%x~~Nʹ6_9f`l[Z6lѡZ;{'BQ1 .@ݻw tE uOl |T@|YaYbho ~_raaPYhHD 5"Z*(Z@v ''l0+م?>~U4:pvp"ֆƺMc@lbFq^MG|e{5 i193u Y[ zyH}kD]b}/Zm7oܖc^-^[i1t99NNov5b,2勋iw&"c5 Nem8p'ZxwWu=saR)yaʓ*|רʧPhr$$3z?<-82l)NDP1e %h|8t!Ëؼ,u Pձ|4 I<{}Eu!7.γ9N*?Nd 4hEh^bn="n9y`p܉N֥靥¿]'ꢿJD ׆QݰI }ސBzY]`Y+ْ{'S+{<;cl,`Xctwf)d'.ϯ35 ҏfe-Ӟ~ ? XY֟|Bc_eM0JDqSipVw3m2nf)QӦv?eʦhۤ( ֦D!2ز7Tw`y}W}H(|h&w"ݎm7"EQiVڬ:G7NNŊi4|zK Ӓ{N'j I5ImW+06J ro},.EC` Y(K /s F4>G&MR3f)K*Of#p"3L:^,O%+ ~\Qd}R聛f_qUFALTN7Snd?pHlI11Bt-ϓ C爆E3{|f6~vgmz JgVL7{-AzzRБdY^u8kC{C; vcT 3vns) b 1@ 51f Vd- 4 (Nڰ(}K@S19QsP@l7LP3`ţ躇=uC]Բ e , ͚$ÉX6A7BMg>`1 Bd &x( YB_rEƖbeD;t8kC~fq"׶B->D !!ADLK nh4]"cxCt1:a1hU eh) MczC}0/c# pǨU nXVd, *4Y`e:^Z?vo#Ei*DêЯ0 B6 n&}3Q1@3]V: P@4P%!FCP@l4LAѣʚ!ȉJ'EBģ#}H,5dQC,U\7c@acqȔBKP@T"@4R a&DC3Vxqiv~Q@߇Ykm?zbm華M~0Q9 =sa/>}eD . ;۷oi8@EXC3_|ׯi_D@EXCGP@lhֆ 0( bNk]$1%a1zDD̆v `m.&"D[6l<&"fF[6l<%"&G+6l;]DD̏V`m v RX* a%$"a!Lh [Xzz G'9"ֆ9QSP@tԱƙhhKP'O[U?H? F?1 VzZ 4-WV0I:aX X!dZh*UDˊV8'bmLfvn~}nP4a1R}OW*Uw xYZ(&CQa6.i.7˰(ZѕX j}D '|"jaBO6cY6oT\s.Dcy&Ƥ< '+U3'ۧN7*[qG]\\ן7RdRǒCOUq7}碹!~=v,>'ϸD><׫.u8kF=L9 <̉1{ߩ )4:3 E`uA>:^#:hk#i胷G1®3zpNץ[qY%%ᱱnVk'_6;8]-/xU7_Y -A,&NgFiU'̜A&|xv[VN'RcJg<5j65K"eY_r$eY[4unǶ-"681w&b4x>2.@r%:ߝyjegm}o!" z|l2XQU=;ZOTVLE/ŵM ߍs v;bKцKr!zxy0uì}E8ljR#ebDɏR(ÉkȰMl2zށ (Hj6~ C8]bQkPp;yz;bؿaKؘHK0a oapXQdBA۬RȢ]i7e,NxNScsޫ ޏe/EvH8@Djܼˌ[ׇ]1>g+3IS)p.%,J^쮮m Ub\(h& E"@V`[z@HKnb,!509ܘXجaAѰ F)z̈nkܣԖoES,<Te29y9K6Wt@4M26O<'u:JUC~,IXsTCkSnt;Eh19? M!򈵠5|4bO)΋/çWBƃp&~. u[S\ u^?%RDE%O [Hi2P;mc|'kBwe=6oQjia.  * @a B p"LP@PDpN   * @4t0@@DC!@8&( h"D8@' @ :D  DC@@4T"@ ha B p"LP@PDpN   * @4t0@@DC!@8&( h"D8@' @ :D   mIENDB`^ 002 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH 8`8 iBNormal_HmH sH tH DA D Default Paragraph FontRiR  Table Normal4 l4a (k (No List HH v Balloon TextCJOJQJ^JaJ4@4 M%dHeader  H$.. M%d Header Char4 "4 M%dFooter  H$.1. M%d Footer CharXP@BX V Body Text 2$da$B*CJ KHOJQJphRQR VBody Text 2 CharB*CJ KHOJQJphB'aB Comment ReferenceCJaJ4r4  Comment Text@jqr@ Comment Subject5\4U4  ";0 Hyperlink >*phJ^@J  ";0 Normal (Web)dd[$\$CJaJPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 3 3j  R  M'N*-03W7";; !#$%&()+,-/013!m#/9;;"'*.24@   @  0(  B S  ?H0(  3y3{3|3~333333333-.0'0{0011y3{3|3~33333333333333# 1$$W/W///T0n0000001#3y3y3|3|333333333333333333# 1$$W/W///T0n0000001x3y3y3{3|3|3~333333333 UVaKSU= 0,>[p2W3UNWh^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH%hpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hH^`o() ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.\\^\`CJOJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH| | ^| `OJQJo(hHLL^L`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHVaKNW3 p2W>=           R>                         n                 3E!cP4"1r1r3E!2D{)\Dt'K?&Vw!]1@jQM6dj&0'er)**+[\,he/v/'73458 9H: ";];K <=T=@pAiByBIhEG!G4Q[S,%VXY@IZMVZ [\j:^)__M%d3yf2gc[i-oq#t+tv8x^z0A{ |xk|"}UTlN1=5-0K3GS6n &|&z5B`&X39=-(SX3_|(,8uN$ #rrw>(J\ _Ss@Im!lDZ/a;9y1V;M.x8O0it{ oRv))SW)E&Vy3{3@3@UnknownHrsaG* Times New Roman5Symbol3. * Arial5. *aTahoma9Garamond?= * Courier New;WingdingsA BCambria Math"hf!rF+ ]+ ]!d24d_3_3 3qHX ?iB2!xx%THE KIDNEY PAIRED DONATION PROGRAM at Johns Hopkinssleemaef$      Oh+'0   4@ ` l x (THE KIDNEY PAIRED DONATION PROGRAM atJohns Hopkins Normal.dotm sleemaef5Microsoft Office Word@@m;@Lrb@ +՜.+,0 hp  Johns Hopkins]_3 &THE KIDNEY PAIRED DONATION PROGRAM at Title  !"#$%&'()*+,-./012345789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_abcdefghijklmnopqrstuvwxyz|}~Root Entry FPl#Data 6R1Table`x5WordDocument7jSummaryInformation({DocumentSummaryInformation8CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q